BioCentury
ARTICLE | Clinical News

Cantab cocaine addiction study on hold

September 6, 2000 7:00 AM UTC

Cantab (LSE:CTB; CNTBY) said vaccinations in its Phase IIa study of TA-CD cocaine derivative coupled with rCTB carrier protein and formulated with alum are on hold due to an adverse event observed in ...